Novel USP30 inhibitors (Mid-Atlantic BioTherapeutics/Accelero Biostructures)

N/A

Report date: 2024/09/25 10:55:23
NME

Base Information

Drug NameNovel USP30 inhibitors (Mid-Atlantic BioTherapeutics/Accelero Biostructures)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin carboxyl-terminal hydrolase 30 inhibitors
TargetsUbiquitin carboxyl-terminal hydrolase 30
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAccelero Biostructures IncMid-Atlantic Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAccelero Biostructures IncMid-Atlantic Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A